We are live on ! Find out more
ADIL

Adial Pharmaceuticals
ADIL

15 hedge funds and large institutions have $1.63M invested in Adial Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

39% more capital invested

Capital invested by funds: $1.17M → $1.63M (+$453K)

36% more funds holding

Funds holding: 11 → 15 (+4)

0% less ownership

Funds ownership: 0.01% → 0.01% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
15
Holders Change
+4
Holders Change %
+36.36%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$76.4K
2
AGM
Alpine Global Management
New York
+$56.8K
3
VF
Virtu Financial
New York
+$27.9K
4
Northern Trust
Northern Trust
Illinois
+$17.7K
5
TRCT
Tower Research Capital (TRC)
New York
+$3.73K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$209K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$129K

ADIL Hedge Fund Activity: Q3 2020 in Review

15 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals (ADIL) for Q3 2020, worth a combined $1.63M — up 39% from $1.17M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ADIL positions and 1 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $76.4K. The largest seller was Bank of America, exiting entirely with an estimated $209K sold.

  • 15 institutional investors held Adial Pharmaceuticals (ADIL) as of Q3 2020, up from 11 in Q2 2020.
  • Funds reported $1.63M of Adial Pharmaceuticals stock for Q3 2020, up 39% quarter-over-quarter.
  • 5 funds opened new Adial Pharmaceuticals positions in Q3 2020 and 1 closed out, a net change of +4 holders.
  • The largest Adial Pharmaceuticals buyer in Q3 2020 was Renaissance Technologies, an estimated $76.4K added.
  • The largest Adial Pharmaceuticals seller in Q3 2020 was Bank of America, an estimated $209K sold.

Based on aggregated 13F filings for Q3 2020.